Surgical treatment for metastatic cancer of the liver
Hepatic metastatic lesion is the most common manifestation of hematogenous metastastic spread of gastrointestinal tumors. Up to now, standard surgical treatment policy has not been elaborated. The Department for Surgery for Hepatic and Pancreatic Tumors has performed 962 hepatic operations of various scopes, of them the operations have been made for metastases of colorectal and non-colorcctal cancer in 468 and 176 patients, respectively. In the latter, metastases of carcinoid tumors, cancer of the stomach and ovaries are most common. After multimodality treatment, the survival median in patients with solitary, multiple, and bilobate colorectal metastases to the liver was 64.2, 38, and 42 months, respectively; after surgical and complex treatments, this was 24 and 46.7 months. The best results of treatment for поп-colorectal metastases to the liver were obtained in patients with adrenal malignancies and hepatocellular carcinoma. Hepatectomy is the only treatment when intrahepatic colorectal metastases; adjuvant chemotherapy is also indicated in all patients. A working classification of surgical treatment policy in metastases of поп-colorectal cancer has been developed by the authors.